Thalidomide in dermatology. New indications for an old drug

被引：41
作者：
Calderon, P [1 ]
Anzilotti, M [1 ]
Phelps, R [1 ]
机构：
[1] Mt Sinai Sch Med, Dept Dermatol, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 1997年 / 36卷 / 12期
关键词：
D O I：
10.1046/j.1365-4362.1997.00298.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：881 / 887
页数：7
相关论文
共 74 条
[21]   CHRONIC CUTANEOUS LUPUS-ERYTHEMATOSUS - THALIDOMIDE TREATMENT OF 11 PATIENTS [J].
HASPER, MF .
ARCHIVES OF DERMATOLOGY, 1983, 119 (10) :812-815
[22]  
HASPER MF, 1982, ACTA DERM-VENEREOL, V62, P321
[23]  
HELLMAN JK, 1969, BRIT MED J, V2, P687
[24]   CHRONIC CUTANEOUS LUPUS-ERYTHEMATOSUS TREATED WITH THALIDOMIDE [J].
HOLM, AL ;
BOWERS, KE ;
MCMEEKIN, TO ;
GASPARI, AA .
ARCHIVES OF DERMATOLOGY, 1993, 129 (12) :1548-1550
[25]   THALIDOMIDE EFFECTS IN BEHCETS-SYNDROME AND PUSTULAR VASCULITIS [J].
JORIZZO, JL ;
SCHMALSTIEG, FC ;
SOLOMON, AR ;
CAVALLO, T ;
TAYLOR, RS ;
RUDLOFF, HB ;
SCHMALSTIEG, EJ ;
DANIELS, JC .
ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (05) :878-881
[26]   TNF-ALPHA REGULATION OF HIV-1 - BIOLOGY AND THERAPY [J].
KAPLAN, G ;
MOREIRA, AL .
RESEARCH IN IMMUNOLOGY, 1994, 145 (8-9) :685-689
[27]   IMMUNOSUPPRESSIVE PROPERTIES OF THALIDOMIDE - INHIBITION OF INVITRO LYMPHOCYTE-PROLIFERATION ALONE AND IN COMBINATION WITH CYCLOSPORINE OR FK506 [J].
KEENAN, RJ ;
EIRAS, G ;
BURCKART, GJ ;
STUART, RS ;
HARDESTY, RL ;
VOGELSANG, G ;
GRIFFITH, BP ;
ZEEVI, A .
TRANSPLANTATION, 1991, 52 (05) :908-910
[28]   THALIDOMIDE IN THE TREATMENT OF 60 CASES OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS [J].
KNOP, J ;
BONSMANN, G ;
HAPPLE, R ;
LUDOLPH, A ;
MATZ, DR ;
MIFSUD, EJ ;
MACHER, E .
BRITISH JOURNAL OF DERMATOLOGY, 1983, 108 (04) :461-466
[29]  
KURKCUOGLU N, 1985, BRIT J DERMATOL, V112, P632
[30]   ELEVATED LEVELS OF CIRCULATING CACHECTIN TUMOR NECROSIS FACTOR IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
LAHDEVIRTA, J ;
MAURY, CPJ ;
TEPPO, AM ;
REPO, H .
AMERICAN JOURNAL OF MEDICINE, 1988, 85 (03) :289-291
12345678